title: Clinical efficacy of arsenic trioxide in a patient with acute promyelocytic leukemia with recurrent central nervous system involvement.
authors: Patrizia
authors: P
authors: Zappasodi
authors: Marianna
authors: M
authors: Rossi
authors: Ilaria
authors: I
authors: Ambaglio
authors: Paolo
authors: P
authors: Bernasconi
authors: Alessandro
authors: A
authors: Corso
authors: Mario
authors: M
authors: Lazzarino
authors: Carlo
authors: C
authors: Castagnola
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000627:therapeutic use*; D002490:Central Nervous System / Q000473:pathology*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D017254:Leukemic Infiltration / Q000473:pathology*; D008577:Meningeal Neoplasms / Q000188:drug therapy*; D010087:Oxides / Q000627:therapeutic use*; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide